Site assessment and audits
Aepodia is experienced in the evaluation of phase I units, hospital-based investigational sites and the different vendors involved in clinical trials. Our evaluations are performed by qualified auditors in accordance with European Medicines Agency INS-GCP-3 Annex 3 and MHRA accreditation standards and with country specific regulations. Our auditors evaluate phase I trial-related vendors according to GCP, GMP, GLP and Computer System Validation requirements. We discuss the results of the audit with you along with any necessary corrective actions or follow-up.